Literature DB >> 11739713

Essential roles for CD8+ T cells and gamma interferon in protection of mice against retrovirus-induced immunosuppression.

Ulf Dittmer1, Brent Race, Karin E Peterson, Ingunn M Stromnes, Ronald J Messer, Kim J Hasenkrug.   

Abstract

It is known that both animal and human retroviruses typically cause immunosuppression in their respective hosts, but the mechanisms by which this occurs are poorly understood. The present study uses Friend virus (FV) infections of mice as a model to determine how major histocompatibility complex (MHC) genes influence immunosuppression. Previously, MHC-I genes were shown to influence antibody responses to potent antigenic challenges given during acute FV infection. The mapping of an immune response to an MHC-I gene implicated CD8+ T cells in the mechanism, so we directly tested for their role by using in vivo CD8+ T-cell depletions. Mice resistant to FV-induced immunosuppression became susceptible when they were depleted of CD8+ T cells. Resistance also required gamma interferon (IFN-gamma), as in vivo neutralization of IFN-gamma converted mice from a resistant to susceptible phenotype. On the other hand, susceptibility to FV-induced immunosuppression was dependent on the immunosuppressive cytokine, interleukin-10 (IL-10), as antibody responses were restored in susceptible mice when IL-10 function was blocked in vivo. Thus, FV-induced immunosuppression of antibody responses involves complex mechanisms controlled at least in part by CD8+ T cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11739713      PMCID: PMC135723          DOI: 10.1128/jvi.76.1.450-454.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Different H-2 subregions influence immunization against retrovirus and immunosuppression.

Authors:  R P Morrison; P L Earl; J Nishio; D L Lodmell; B Moss; B Chesebro
Journal:  Nature       Date:  1987 Oct 22-28       Impact factor: 49.962

2.  Specific cytotoxic T cells eliminate B cells producing virus-neutralizing antibodies [corrected].

Authors:  O Planz; P Seiler; H Hengartner; R M Zinkernagel
Journal:  Nature       Date:  1996-08-22       Impact factor: 49.962

Review 3.  Immunity to retroviral infection: the Friend virus model.

Authors:  K J Hasenkrug; B Chesebro
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

4.  Characterization of glycosylated Gag expressed by a neurovirulent murine leukemia virus: identification of differences in processing in vitro and in vivo.

Authors:  R Fujisawa; F J McAtee; J H Zirbel; J L Portis
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  Suppression of virus-specific antibody production by CD8+ class I-restricted antiviral cytotoxic T cells in vivo.

Authors:  D Moskophidis; H Pircher; I Ciernik; B Odermatt; H Hengartner; R M Zinkernagel
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

6.  Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus-induced erythroleukemia cells: friend-specific and FMR-specific antigens.

Authors:  B Chesebro; K Wehrly; M Cloyd; W Britt; J Portis; J Collins; J Nishio
Journal:  Virology       Date:  1981-07-15       Impact factor: 3.616

7.  Interleukin-12 administration in retroviral infection of mice increases the potential to produce functional dendritic cells from bone marrow stem cells.

Authors:  P Kelleher; N J Williams; S C Knight
Journal:  Immunol Lett       Date:  1999-01       Impact factor: 3.685

8.  Immunoprotective determinants in friend murine leukemia virus envelope protein.

Authors:  K J Hasenkrug; D M Brooks; M N Robertson; R V Srinivas; B Chesebro
Journal:  Virology       Date:  1998-08-15       Impact factor: 3.616

Review 9.  Immunosuppression by retroviruses: implications for xenotransplantation.

Authors:  J Denner
Journal:  Ann N Y Acad Sci       Date:  1998-12-30       Impact factor: 5.691

Review 10.  Molecular biology of Friend viral erythroleukemia.

Authors:  D Kabat
Journal:  Curr Top Microbiol Immunol       Date:  1989       Impact factor: 4.291

View more
  33 in total

1.  CD8+ T-cell dysfunction due to cytolytic granule deficiency in persistent Friend retrovirus infection.

Authors:  Gennadiy Zelinskyy; Shelly J Robertson; Simone Schimmer; Ronald J Messer; Kim J Hasenkrug; Ulf Dittmer
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

2.  Effect of host genetics on the development of cytomegalovirus retinitis in patients with AIDS.

Authors:  Efe Sezgin; Douglas A Jabs; Sher L Hendrickson; Mark Van Natta; Alexander Zdanov; Richard Alan Lewis; Michael W Smith; Jennifer L Troyer; Stephen J O'Brien
Journal:  J Infect Dis       Date:  2010-08-15       Impact factor: 5.226

3.  Neutrophils are essential for induction of vaccine-like effects by antiviral monoclonal antibody immunotherapies.

Authors:  Mar Naranjo-Gomez; Jennifer Lambour; Marc Piechaczyk; Mireia Pelegrin
Journal:  JCI Insight       Date:  2018-05-03

4.  Preinfection treatment of resistant mice with CpG oligodeoxynucleotides renders them susceptible to friend retrovirus-induced leukemia.

Authors:  Anke R M Olbrich; Simone Schimmer; Ulf Dittmer
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 5.  Tetherin/BST-2: Restriction Factor or Immunomodulator?

Authors:  Sam X Li; Bradley S Barrett; Kejun Guo; Mario L Santiago
Journal:  Curr HIV Res       Date:  2016       Impact factor: 1.581

6.  Toll-like receptor 7 inhibits early acute retroviral infection through rapid lymphocyte responses.

Authors:  Edward P Browne
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

7.  Suppression of acute anti-friend virus CD8+ T-cell responses by coinfection with lactate dehydrogenase-elevating virus.

Authors:  Shelly J Robertson; Christoph G Ammann; Ronald J Messer; Aaron B Carmody; Lara Myers; Ulf Dittmer; Savita Nair; Nicole Gerlach; Leonard H Evans; William A Cafruny; Kim J Hasenkrug
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

8.  IFN-α treatment inhibits acute Friend retrovirus replication primarily through the antiviral effector molecule Apobec3.

Authors:  Michael S Harper; Bradley S Barrett; Diana S Smith; Sam X Li; Kathrin Gibbert; Ulf Dittmer; Kim J Hasenkrug; Mario L Santiago
Journal:  J Immunol       Date:  2013-01-11       Impact factor: 5.422

Review 9.  Humoral immunity in the Friend retrovirus infection model.

Authors:  Kalani Halemano; Michael S Harper; Kejun Guo; Sam X Li; Karl J Heilman; Bradley S Barrett; Mario L Santiago
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

10.  Novel role of CD8(+) T cells and major histocompatibility complex class I genes in the generation of protective CD4(+) Th1 responses during retrovirus infection in mice.

Authors:  Karin E Peterson; Ingunn Stromnes; Ron Messer; Kim Hasenkrug; Bruce Chesebro
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.